← Leaderboards
Stacy Lynn Gelhaus
University Of Pennsylvania
$3,629,070
Attributed
$5,490,715
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,490,715 · 7
By mechanism
R33$2,285,261 · 1
S10$1,193,679 · 2
R61$741,557 · 1
R01$696,473 · 1
R21$425,563 · 1
F32$148,182 · 1
Top collaborators
- Fernando Holguin4 shared
- Michelle Lynn Manni1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Trevor M. Penning$29,812,455
- Meenhard Herlyn$50,214,821
- Ian Alexander Blair$30,276,296
- Zhaoyu Li$1,198,275
- Hejia Henry Wang$112,868
Others in their field
Top investigators on “Metabolic”
- David M Nathan · Massachusetts Institute Of Technology$157,845,616
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$144,157,234
- Judith S. Currier · University Of California Los Angeles$141,260,706
- John M Lachin · George Washington University$139,991,329
- Randall J Bateman · Washington University$124,168,384
- Carol Nesel · Westat$116,355,411
Research focus
MetabolicLungMetabolismMediatingEnzymesReactionPharmaceutical PreparationsCellsSignal TransductionBody Mass IndexSymptomsInflammatoryAirway HyperresponsivenessResponsePre-ClinicalPhenotypePublishingAsthmaticAsthmaCytokinePlasmaBiologicalObesityTranscription Factor
Grant awards (12)
LIMA: Lipid anti-Inflammatory Mediators in Asthma to reduce airway hyperresponsiveness in obese asthmatics$759,073
R33 · FY2025 · HL
Microbial-derived metabolites potentiate airway hyperresponsiveness in obesity-associated asthma$696,473
R01 · FY2025 · HL · contact PI
LIMA: Lipid anti-Inflammatory Mediators in Asthma to reduce airway hyperresponsiveness in obese asthmatics$752,287
R33 · FY2024 · HL
LIMA: Lipid anti-Inflammatory Mediators in Asthma to reduce airway hyperresponsiveness in obese asthmatics$773,901
R33 · FY2023 · HL
LIMA: Lipid anti-Inflammatory Mediators in Asthma to reduce airway hyperresponsiveness in obese asthmatics$741,557
R61 · FY2022 · HL
An Exploris 240 for Metabolomics$600,000
S10 · FY2022 · OD · contact PI
Bringing Untargeted Metabolomics to Pitt$593,679
S10 · FY2018 · OD · contact PI
The Effects of Nitrate/Nitrite and Conjugated Linoleic Acid Supplementation on the Obese Asthmatic Pathology$233,063
R21 · FY2017 · AI · contact PI
The Effects of Nitrate/Nitrite and Conjugated Linoleic Acid Supplementation on the Obese Asthmatic Pathology$192,500
R21 · FY2016 · AI · contact PI
Defining PAH-mediated carcinogenesis in lung: CYP metabolism and B[a]P transport$51,710
F32 · FY2009 · ES · contact PI
Defining PAH-mediated carcinogenesis in lung: CYP metabolism and B[a]P transport$49,646
F32 · FY2008 · ES · contact PI
Defining PAH-mediated carcinogenesis in lung: CYP metabolism and B[a]P transport$46,826
F32 · FY2007 · ES · contact PI